Aimovig 140 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F91SP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $84,949
Award facts
- Contract value 100% obligated
- $84,948.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 2, 2025, for the supply of Aimovig 140 mg/ml autoinjectors. The contract, valued at $84,948.67, carries a firm fixed-price structure with an ultimate completion date of December 3, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Aimovig is a calcitonin gene-related peptide (CGRP) antagonist used in the treatment of migraines, representing a specialized pharmaceutical requirement within the federal healthcare supply chain.
This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Through this contract structure, AmerisourceBergen provides critical pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, supporting the DLA's mission to meet medical supply needs across the Department of Defense enterprise.
Quick answers
Who was awarded contract SPE2DR26F91SP?
SPE2DR26F91SP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F91SP worth?
The government has obligated $84,949 on SPE2DR26F91SP.
Is contract SPE2DR26F91SP an order under another contract?
Yes. SPE2DR26F91SP is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91SP competed?
The extent of competition for SPE2DR26F91SP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award